Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lassmann

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2008
Guidelines for radioiodine therapy of differentiated thyroid cancerM Luster, S E Clarke, M Dietlein, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3)]M Dietlein, J Dressler, W Eschner, et al.
Journal of Endocrinological Investigation|September 27, 2000
The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH productionM Luster, W Reinhardt, C Korber, et al.
Medical Physics|October 5, 2013
Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficientP Kletting, S Schimmel, H A Kestler, et al.
International Journal of Oncology|May 3, 2011
Effect of specific activity on organ uptake of iodine-123-meta-iodobenzylguanidine in humansJ Farahati, M Lassmann, M Scheubeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1997
Effect of specific activity on cardiac uptake of iodine-123-MIBGJ Farahati, D Bier, M Scheubeck, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)]M Dietlein, J Dressler, W Eschner, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|November 14, 2009
Individualized dosimetry in the management of metastatic differentiated thyroid cancerC Chiesa, M R Castellani, C Vellani, et al.
Nuklearmedizin. Nuclear Medicine|March 21, 2006
[Radiation exposure in (90)Y-Zevalin therapy: results of a prospective multicentre trial]L Geworski, K Zöphel, A Rimpler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2021
DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with <sup>131</sup>IS Schumann, H Scherthan, K Pfestroff, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2008
Guidelines for radioiodine therapy of differentiated thyroid cancerM Luster, S E Clarke, M Dietlein, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guideline for iodine-131 whole-body scintigraphy for differentiated thyroid cancer (version 3)]M Dietlein, J Dressler, W Eschner, et al.
Journal of Endocrinological Investigation|September 27, 2000
The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH productionM Luster, W Reinhardt, C Korber, et al.
Medical Physics|October 5, 2013
Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficientP Kletting, S Schimmel, H A Kestler, et al.
International Journal of Oncology|May 3, 2011
Effect of specific activity on organ uptake of iodine-123-meta-iodobenzylguanidine in humansJ Farahati, M Lassmann, M Scheubeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1997
Effect of specific activity on cardiac uptake of iodine-123-MIBGJ Farahati, D Bier, M Scheubeck, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)]M Dietlein, J Dressler, W Eschner, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|November 14, 2009
Individualized dosimetry in the management of metastatic differentiated thyroid cancerC Chiesa, M R Castellani, C Vellani, et al.
Nuklearmedizin. Nuclear Medicine|March 21, 2006
[Radiation exposure in (90)Y-Zevalin therapy: results of a prospective multicentre trial]L Geworski, K Zöphel, A Rimpler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2021
DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with <sup>131</sup>IS Schumann, H Scherthan, K Pfestroff, et al.
Pageof 5